Techsomed

Techsomed is an Israel-based medical technology company founded in 2012. The company specializes in developing advanced image analysis systems for monitoring cancer treatment, particularly focusing on thermal ablation therapy. Their core product integrates with standard ultrasound devices to provide real-time tracking of tissue response during procedures that destroy tumors using extreme heat or cold. This system allows surgeons to visualize immediate effects and simulate tissue response over the next 24 hours, enhancing control and accuracy during treatment. Techsomed's technology is particularly beneficial for liver cancer and other tumors treated with thermal ablation. The company has secured significant funding, including a $2.6 million investment led by Johnson & Johnson Innovation, which supports their efforts to obtain regulatory approvals in major markets like the U.S., European Union, and Japan. Techsomed collaborates with partners such as Lenovo to optimize their imaging algorithms for clinical environments, facilitating the global distribution of their BioTrace system across multiple clinical sites.

• Employees 27
• Founded 2012
• Total Funding $9600000